Vinita D. Gupta

Last updated

Vinita D. Gupta
Born1968or1969(age 55–56) [1]
NationalityIndian
Education University of Mumbai
Kellogg School of Management
OccupationBusinesswoman
TitleCEO, Lupin Limited
TermSeptember 2013-
Board member ofLupin Limited
Intrexon
SpouseBrij Sharma
Children1
Parent Desh Bandhu Gupta
Relatives Nilesh Gupta (brother)

Vinita D. Gupta (born 1968/1969) is an Indian businesswoman, the chief executive officer (CEO) of Lupin Limited since September 2013, [1] and the chairperson of Lupin Inc (LI), and its US subsidiary, Lupin Pharmaceuticals Inc (LPI).[ citation needed ]

Contents

Early life

Vinita D. Gupta is the eldest daughter of Desh Bandhu Gupta, [2] who founded Lupin in 1968.

She earned a bachelor's degree in pharmacy from the University of Mumbai, and an MBA from the Kellogg School of Management, US. [1]

Career

Gupta joined Lupin in 1993, [3] and became CEO in 2013.

Gupta was the chairman and CEO of Lupin Pharmaceuticals Inc, from 2003 to 2013, and grew the US business from 5% to over 45% of Lupin's total turnover. [2]

The US is Lupin's largest market.[ citation needed ] Lupin's estimated annual cost savings to the US health system is approximately $15 billion.[ citation needed ] In March 2016, the company acquired Gavis Pharmaceuticals in Somerset, NJ for $880 million.[ citation needed ] Lupin has invested over $1 billion for the US market in 2016.[ citation needed ] Lupin employs 674 employees in the US.[ citation needed ]

In April 2017, Gupta was appointed a non-executive director of Intrexon. [4]

Gupta and her brother Nilesh Gupta, managing director of Lupin Limited, were jointly named Ernst & Young Entrepreneur of The Year for India 2015, [5] and won the Forbes India Leadership Awards 2016 – Entrepreneur of the Year.[ citation needed ] She was the winner of the inaugural EY, U.S. 2012 Family Business Award of Excellence and EY Entrepreneur Of The Year 2012 award winner for the Health Services and Technology for Maryland.[ citation needed ] She was named by Forbes Asia in its Top 50 power businesswomen for Asia Pacific in 2014. [6] She entered the Hall of Fame – Most Powerful Women in Business 2016 – Business Today and was named Outstanding Business Woman Leader of the Year - 11th CNBC India Business Leader Awards.[ citation needed ]

Personal life

She is married to Brij Sharma, a US-based millionaire investor and entrepreneur, they have a son named Krish Sharma, and live in Florida, US. [7] [3]

Related Research Articles

Gupta is a common surname or last name of Indian origin. It is based on the Sanskrit word गोप्तृgoptṛ, which means 'guardian' or 'protector'. According to historian R. C. Majumdar, the surname Gupta was adopted by several different communities in northern and eastern India at different times.

<span class="mw-page-title-main">Cipla</span> Indian multinational pharmaceutical company

Cipla Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. Cipla primarily focuses on developing medication to treat respiratory disease, cardiovascular disease, arthritis, diabetes, depression, and various other medical conditions. Cipla has 47 manufacturing locations across the world and sells its products in 86 countries. It is the third-largest drug producer in India.

<span class="mw-page-title-main">Dilip Shanghvi</span> Indian Businessman

Dilip Shanghvi is an Indian billionaire businessman. As the founder of Sun Pharmaceuticals, he is one of the country's richest people. The Government of India awarded him the civilian honor of the Padma Shri in 2016. India Today magazine ranked him 8th in India's most powerful people of 2017 list.

<span class="mw-page-title-main">Ajay Piramal</span> Indian businessman

Ajay Gopikisan Piramal is an Indian billionaire businessman, and the chairman of the Piramal Group, a conglomerate with interests in pharmaceutical, financial services, real estate, healthcare analytics and glass packaging. As of July 2024, his net worth is estimated at US$2.8 billion.

Fred Hassan, is a Pakistan-born American business executive who works for Warburg Pincus and was CEO of three global pharmaceutical companies.

Randal J. Kirk is an American billionaire businessman and investor in pharmaceuticals and biotechnology. Kirk was the chairman and chief executive officer of Intrexon, a biotechnology company, until 2020. Kirk started as a lawyer, but is best known for his investments in pharmaceutical and biotech companies. In addition to high-profile sales of New River Pharmaceuticals, and Clinical Data, Kirk founded investment firm Third Security, and has held board seats with biotech companies, such as Scios. As of May 2024, Forbes estimated his net worth at US$1.4 billion.

<span class="mw-page-title-main">Anand Mahindra</span> Indian businessman

Anand Gopal Mahindra is an Indian billionaire businessman, and the chairman of Mahindra Group, a Mumbai-based business conglomerate. The group operates in aerospace, agribusiness, aftermarket, automotive, components, construction equipment, defence, energy, farm equipment, finance and insurance, industrial equipment, information technology, leisure and hospitality, logistics, real estate and retail. Mahindra is the grandson of Jagdish Chandra Mahindra, co-founder of Mahindra & Mahindra.

Romesh T. Wadhwani is an Indian-American billionaire, businessman and head of investment firm SAIGroup. He is the former chairman and CEO of Symphony Technology Group, a private equity firm for software, Internet and technology services companies. He established the Wadhwani Foundation for economic development in emerging economies, with an initial focus on India. Initiatives in India include the National Entrepreneurship Network.

<span class="mw-page-title-main">Lupin Limited</span> Indian multinational pharmaceutical company

Lupin Limited is an Indian multinational pharmaceutical company based in Mumbai. It is one of the largest generic pharmaceutical companies by revenue globally. The company's key focus areas include paediatrics, cardiovascular, anti-infectives, diabetology, asthma and anti-tuberculosis.

Dennis M. Jones was an American businessman and pharmaceutical magnate, best known as the founder of Jones Pharma and Dennis M. Jones Family Foundation.

<span class="mw-page-title-main">Desh Bandhu Gupta</span> Indian billionaire, philanthropist, entrepreneur

Desh Bandhu Gupta was an Indian billionaire, philanthropist, entrepreneur and the founder of Lupin Limited, a multinational pharmaceutical company. At the time of his death, his net worth was estimated at US$3.6 billion.

<span class="mw-page-title-main">SRF Limited</span> Indian manufacturing company

SRF Limited is an Indian multi-business chemicals conglomerate engaged in the manufacturing of industrial and specialty intermediates. The company’s business portfolio covers fluorochemicals, specialty chemicals, packaging films, technical textiles, coated and laminated fabrics. It has a workforce of more than 8,000 employees across eleven manufacturing plants in India Thailand, South Africa and Hungary. The company exports to more than 90 countries.

Shikha Sharma is an Indian economist and banker. She was the managing director and CEO of Axis Bank from 2009 to 2018. She also worked for nearly thirty years at the ICICI Group, across its bank and insurance companies.

Arie S. Belldegrun, FACS, is an Israeli-American urologic oncologist, billionaire businessman and investor.

<span class="mw-page-title-main">Ramesh Juneja</span> Indian businessperson (born 1955)

Ramesh C. Juneja is an Indian billionaire businessman and the Chairman of Mankind Pharma. He is one of the 100 richest Indians as per Forbes; his net worth was estimated to be $2.3 billion in 2019.

<span class="mw-page-title-main">Aditya Puri</span> Ex-managing director of HDFC Bank

Aditya Puri is a senior advisor at The Carlyle Group. He was the managing director of HDFC Bank, India's largest private sector bank. He assumed this position in September 1994. Puri was the longest-serving head of any private bank in the country. India Today ranked him at #24 in India's 50 Most Powerful People of 2017 list.

<span class="mw-page-title-main">Aneel Bhusri</span> Indian-American business executive

Aneel Bhusri is an American business executive. He is the chief executive officer (CEO) of Workday. He is also a partner at Greylock Partners and was a member of Intel's board of directors between 2014 and 2019. Bhusri has been a billionaire since 2014; as of 2021 he has a net worth of $3.1 billion.

<span class="mw-page-title-main">Vijay Shekhar Sharma</span> Founder and CEO of Paytm

Vijay Shekhar Sharma is an Indian technology entrepreneur and multimillionaire business magnate. He is the founder chairman, and managing director of One97 Communications founded in 1997 and its consumer brand Paytm which he started in 2010.

Narendra K. Gupta was an Indian-American venture capital investor and technology entrepreneur. He founded the investment company Nexus Venture Partners, as well as various other investment and software firms. He was also CEO and president of Integrated Systems Inc. (ISI) for a decade and a half. In a career spanning over three decades he was recognized for his contributions to global technology and entrepreneurial ecosystems, and for venture capital investments in India.

Nilesh Gupta is an Indian businessman, the managing director (MD) of Lupin Limited since September 2013.

References

  1. 1 2 3 Stocks. "Executive Profile: Vinita D. Gupta". Bloomberg LP. Retrieved 8 May 2019.
  2. 1 2 "MPW 2015: Lupin CEO Vinita Gupta's decisions have seldom gone wrong". Businesstoday.in. 27 September 2015. Retrieved 26 June 2017.
  3. 1 2 "Setting the pace- Business News". Businesstoday.in. 31 December 2016. Retrieved 26 June 2017.
  4. "Intrexon Appoints Vinita Gupta, Leading Pharma Executive, to its Board of Directors - Apr 27, 2017". Investors.dna.com. 27 April 2017. Retrieved 26 June 2017.
  5. "Vinita and Nilesh Gupta of Lupin Limited win EY Entrepreneur Of The Year Award 2015". www.ey.com. 11 February 2016. Retrieved 30 July 2018.
  6. "Vinita Gupta, 45 (India)". Forbes. Archived from the original on 3 March 2014. Retrieved 8 May 2019.
  7. Soumonty Kanungo (3 August 2015). "Architect of Lupin's Rs 5,600-cr deal is Indian star in US pharma space | Latest News & Updates at Daily News & Analysis". Dnaindia.com. Retrieved 26 June 2017.